EMMPRIN-mediated induction of uterine and vascular matrix metalloproteinases during pregnancy and in response to estrogen and progesterone
about
Altered matrix metalloproteinase-2 and -9 expression/activity links placental ischemia and anti-angiogenic sFlt-1 to uteroplacental and vascular remodeling and collagen deposition in hypertensive pregnancy.Matrix Metalloproteinases as Regulators of Vein Structure and Function: Implications in Chronic Venous Disease.Increased vascular and uteroplacental matrix metalloproteinase-1 and -7 levels and collagen type I deposition in hypertension in pregnancy: role of TNF-α.Extracellular matrix in epitheliochorial, endotheliochorial and haemochorial placentation and its potential application for regenerative medicine.Predictive value of serum progesterone level on β-hCG check day in women with previous repeated miscarriages after in vitro fertilization.Matrix Metalloproteinases in Normal Pregnancy and Preeclampsia.Effect of Pregnancy and Delivery on Cytokine Expression in a Mouse Model of Pelvic Organ Prolapse.Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease.Angiogenic imbalance and diminished matrix metalloproteinase-2 and -9 underlie regional decreases in uteroplacental vascularization and feto-placental growth in hypertensive pregnancy.The MMP-9/TIMP-1 System is Involved in Fluoride-Induced Reproductive Dysfunctions in Female Mice.Decreased homodimerization and increased TIMP-1 complexation of uteroplacental and uterine arterial matrix metalloproteinase-9 during hypertension-in-pregnancy.Matrix Metalloproteinases in Remodeling of Lower Extremity Veins and Chronic Venous Disease.Adaptive Reduction of Human Myometrium Contractile Activity in Response to Prolonged Uterine Stretch during Term and Twin Pregnancy. Role of TREK-1 Channel.Placental Growth Factor Reverses Decreased Vascular and Uteroplacental MMP-2 and -9 and increased MMP-1 and -7 and Collagen I and IV in Hypertensive Pregnancy.Diverse roles of prostaglandins in blastocyst implantation
P2860
Q33665037-AF14B204-AFB0-4584-868A-EB05C2D9C037Q36316444-3AE296B7-4D76-4AA9-8C43-F570BF33817EQ38720237-BBEF4179-30DA-4DA7-97F7-E220872A96B5Q39031338-5E212BE3-9D32-4D79-8F2E-4A189BB240C9Q41017573-DD24F928-723C-4D89-BBF3-03F5C1291D68Q46342648-329C7E8A-B6F0-40B1-AC83-3FB8EE4C56A5Q46418912-A2C1E864-1DFE-43D8-AA75-976CEC02BE3AQ47223491-E502146A-6FB3-477D-A7DB-02B8D6B97CE8Q47799852-E3211A05-DE60-45B7-8926-58A0400093F5Q47896631-88BBCE8A-445D-4F36-A7BC-40D98C46CAA3Q51000408-8D31EC0A-7FCD-4A49-835D-7E928442BAEDQ51055817-335977CB-AF75-4766-A989-48A4E3C3FAE4Q51734895-6C7F06F9-9D26-45B9-A34C-6AE0609D377CQ54119733-796504D6-8F9F-4DB3-89F4-921523802A81Q59101169-DB2784DA-43CA-4D09-8F6D-A7550AD346FE
P2860
EMMPRIN-mediated induction of uterine and vascular matrix metalloproteinases during pregnancy and in response to estrogen and progesterone
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
EMMPRIN-mediated induction of ...... e to estrogen and progesterone
@en
EMMPRIN-mediated induction of ...... to estrogen and progesterone.
@nl
type
label
EMMPRIN-mediated induction of ...... e to estrogen and progesterone
@en
EMMPRIN-mediated induction of ...... to estrogen and progesterone.
@nl
prefLabel
EMMPRIN-mediated induction of ...... e to estrogen and progesterone
@en
EMMPRIN-mediated induction of ...... to estrogen and progesterone.
@nl
P2093
P2860
P1476
EMMPRIN-mediated induction of ...... e to estrogen and progesterone
@en
P2093
Raouf A Khalil
Victoria Tran
Yiping Dang
P2860
P304
P356
10.1016/J.BCP.2013.06.030
P407
P577
2013-07-13T00:00:00Z